伊尔斯病的临床特征及不同干预措施对新生血管并发症的疗效
该系统评价纳入47项研究、3557例患者和4959只眼,汇总分析伊尔斯病的临床特征及不同干预对新生血管并发症的疗效。结果显示患者以男性为主(94%)、双眼受累(64%),常见体征包括硬化血管(83%)、视网膜其他部位新生血管(64%)和静脉周围炎(51%);激光光凝后需行玻璃体切除术的比例为19%,抗VEGF治疗可获82%视力改善率但视网膜脱离可能性为18%,玻璃体切除术视力改善率为56%且17%需二次手术。
要点
- 伊尔斯病以年轻男性为主(94%),双眼受累占64%,常见体征为硬化血管(83%)和视网膜其他部位新生血管(64%)。
- 玻璃体出血是最常见并发症,其次为白内障和视网膜脱离;超过半数患者首诊时视力下降。
- 激光光凝针对无灌注或新生血管区,后续玻璃体切除术发生率为19%;抗VEGF治疗后视力改善率为82%、视网膜脱离可能性为18%;玻璃体切除术视力改善率为56%,17%需二次手术。
核心结论
- 伊尔斯病最常见于年轻男性,临床表现多样,治疗应基于疾病进展程度。
研究设计与样本
- 系统评价与汇总分析,检索PubMed、EMBASE和Ovid数据库自建库至2021年2月,纳入47项研究、3557例患者和4959只眼,采用R软件3.6.3版进行统计分析。
主要发现
- 汇总结果显示伊尔斯病以男性为主(94%)、双眼受累(64%),主要发生于青少年。
- 约83%患者Mantoux试验阳性,31%患者玻璃体穿刺聚合酶链反应结核基因组阳性。
- 超过半数患者首诊时视力下降,常见体征包括硬化血管(83%)、视网膜其他部位新生血管(64%)和静脉周围炎(51%),24%患者可检出黄斑改变。
- 最常见并发症为玻璃体出血,其次为白内障和视网膜脱离。
- 激光光凝针对无灌注或新生血管区,后续玻璃体切除术发生率降至19%;抗血管内皮生长因子治疗建议用于玻璃体出血,视力改善率达82%,但视网膜脱离可能性增至18%;玻璃体切除术适用于持续性玻璃体出血或视网膜脱离,56%患者视力改善,17%患者需二次玻璃体切除术,主要原因为复发性玻璃体出血或视网膜脱离。
关键数值与推荐
- 激光光凝针对无灌注或新生血管区,后续玻璃体切除术发生率为19%。
- 抗血管内皮生长因子治疗建议用于玻璃体出血,视力改善率为82%,视网膜脱离可能性为18%。
- 玻璃体切除术适用于持续性玻璃体出血或视网膜脱离,56%患者视力改善,17%患者需二次玻璃体切除术。
临床怎么用
- 原文结论指出伊尔斯病临床表现多样,管理应基于疾病进展程度。
- 原文提及激光光凝针对无灌注或新生血管区,抗血管内皮生长因子治疗建议用于玻璃体出血,玻璃体切除术适用于持续性玻璃体出血或视网膜脱离。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate clinical features and manifestations of Eales disease and the efficacy of different interventions. METHODS: The databases PubMed, EMBASE, and Ovid from inception until February 2021 were searched. Pooled analyses included 1) presenting features, 2) symptoms and signs, and 3) postoperative vision outcomes and complications. Statistical analyses were conducted with R software version 3.6.3. RESULTS: Forty-seven studies involving 3,557 patients and 4,959 eyes were included. The pooling results showed that Eales disease was male dominated (94%), bilateral involvement (64%), and mainly occurred in adolescents. Approximately 83% of patients were positive in Mantoux test, and 31% of patients have vitreous tap polymerase chain reaction positive for tuberculosis genome. More than half of the patients had decreased vision at the first clinic visit. The common signs of Eales disease included sclerotic vessels (83%), neovascularization of retina elsewhere (64%) and periphlebitis (51%). Macular changes could be detected in 24% of patients. The most common complication was vitreous hemorrhage, followed by cataracts and retinal detachment. Photocoagulation was directed at nonperfusion or neovascularization areas, with a decrease in the incidence of later pars plana vitrectomy (19%). Anti-vascular endothelial growth factor treatment was suggested for vitreous hemorrhage, which could achieve high visual acuity improvement rate (82%) while increasing the possibility of retinal detachment (18%). Pars plana vitrectomy was indicated in cases with persistent vitreous hemorrhage or retinal detachment, with 56% of patients obtaining visual improvement. Still, 17% of patients needed a second pars plana vitrectomy, mainly because of recurrent vitreous hemorrhage or retinal detachment. CONCLUSION: Eales disease most commonly affects young men. It has diverse clinical features, and management should be based on the progression of the disease.
引用
- Zhao XY, Cheng SY, Zhang WF, et al. CLINICAL CHARACTERISTICS OF EALES DISEASE AND THE EFFICACY OF DIFFERENT INTERVENTIONS FOR NEOVASCULAR COMPLICATIONS. Retina. 2022. PMID: 36129269. doi:10.1097/IAE.0000000000003534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。